These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16024566)

  • 1. Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension.
    Rondelet B; Kerbaul F; Van Beneden R; Hubloue I; Huez S; Fesler P; Remmelink M; Brimioulle S; Salmon I; Naeije R
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2319-24. PubMed ID: 16024566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling molecules in overcirculation-induced pulmonary hypertension in piglets: effects of sildenafil therapy.
    Rondelet B; Kerbaul F; Van Beneden R; Motte S; Fesler P; Hubloue I; Remmelink M; Brimioulle S; Salmon I; Ketelslegers JM; Naeije R
    Circulation; 2004 Oct; 110(15):2220-5. PubMed ID: 15466636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sitaxsentan for the prevention of experimental shunt-induced pulmonary hypertension.
    Rondelet B; Kerbaul F; Vivian GF; Hubloue I; Huez S; Fesler P; Remmelink M; Brimiouille S; Salmon I; Naeije R
    Pediatr Res; 2007 Mar; 61(3):284-8. PubMed ID: 17314684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil added to sitaxsentan in overcirculation-induced pulmonary arterial hypertension.
    Rondelet B; Dewachter L; Kerbaul F; Dewachter C; Hubloue I; Fesler P; Franck S; Remmelink M; Brimioulle S; Naeije R
    Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1118-23. PubMed ID: 20693396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin A receptor blockade improves regression of flow-induced pulmonary vasculopathy in piglets.
    Mercier O; Sage E; Izziki M; Humbert M; Dartevelle P; Eddahibi S; Fadel E
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):677-83. PubMed ID: 20723731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension.
    Rondelet B; Kerbaul F; Motte S; van Beneden R; Remmelink M; Brimioulle S; McEntee K; Wauthy P; Salmon I; Ketelslegers JM; Naeije R
    Circulation; 2003 Mar; 107(9):1329-35. PubMed ID: 12628956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin attenuates pulmonary vascular remodelling by down-regulating matrix metalloproteinase-1 and -9 expression in a carotid artery-jugular vein shunt pulmonary hypertension model in rats.
    Yao J; Xiong M; Tang B; Chen G; Liang M; Ma X; Wang Z; Wu Z
    Eur J Cardiothorac Surg; 2012 Nov; 42(5):e121-7. PubMed ID: 23087098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension.
    Chassagne C; Eddahibi S; Adamy C; Rideau D; Marotte F; Dubois-Randé JL; Adnot S; Samuel JL; Teiger E
    Am J Respir Cell Mol Biol; 2000 Mar; 22(3):323-32. PubMed ID: 10696069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of Losartan on expression of heme oxygenases in volume-overloaded rats with left-to-right shunt].
    Yuan LX; Liu HM; Li M; Gao J; Zhou TF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):668-71. PubMed ID: 16235533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure.
    Rondelet B; Dewachter C; Kerbaul F; Kang X; Fesler P; Brimioulle S; Naeije R; Dewachter L
    Eur Heart J; 2012 Apr; 33(8):1017-26. PubMed ID: 21606077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
    Zheng Y; Ma H; Hu E; Huang Z; Cheng X; Xiong C
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):504-14. PubMed ID: 26535780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Losartan ameliorates "upstream" pulmonary vein vasculopathy in a piglet model of pulmonary vein stenosis.
    Zhu J; Ide H; Fu YY; Teichert AM; Kato H; Weisel RD; Maynes JT; Coles JG; Caldarone CA
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2550-7. PubMed ID: 25172325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of flow-induced pulmonary arterial vasculopathy after flow correction in piglets.
    Mercier O; Sage E; de Perrot M; Tu L; Marcos E; Decante B; Baudet B; Hervé P; Dartevelle P; Eddahibi S; Fadel E
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1538-46. PubMed ID: 19464477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrasentan treatment of pulmonary vascular disease in piglets with increased pulmonary blood flow.
    Gorenflo M; Ullmann MV; Herpel E; Neumayer S; Dieckmann R; Demirakca S; Klimpel H; Hagl S; Gebhard MM
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):286-92. PubMed ID: 17878757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery-jugular vein shunt pulmonary hypertension rat model.
    Ma X; Yao J; Yue Y; Du S; Qin H; Hou J; Wu Z
    Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):206-211. PubMed ID: 28475806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of MMP-2,9 and TIMP-1 expressions in rats with pulmonary arterial hypertension after captopril and losartan interventions].
    Wang XM; Zhou TF; Liu B; Wei L; Shi K; Zhao SS; Hua YM; Liu HM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):255-9. PubMed ID: 19462901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale.
    Kiely DG; Cargill RI; Wheeldon NM; Coutie WJ; Lipworth BJ
    Cardiovasc Res; 1997 Jan; 33(1):201-8. PubMed ID: 9059545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure.
    Ray L; Mathieu M; Jespers P; Hadad I; Mahmoudabady M; Pensis A; Motte S; Peters IR; Naeije R; McEntee K
    Exp Physiol; 2008 Mar; 93(3):434-42. PubMed ID: 17993509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension.
    Takahashi H; Goto N; Kojima Y; Tsuda Y; Morio Y; Muramatsu M; Fukuchi Y
    Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L450-8. PubMed ID: 16361357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.